Jimmy Lin: Rediscovering Humanity in the Post-Genomic Era

Posted on March 01, 2017

Dr. Cheng-Ho Jimmy Lin will deliver the 2017 Beimfohr Lecture March 1 at 8 p.m. Lin is the Chief Scientific Officer of oncology at Natera, where he is leading the development of new diagnostic technologies for cancer. He has published in top academic journals, such as Science, Nature, and Cell, and has been featured in media outlets, such as New York Times, Forbes, Bloomberg Businessweek, Washington Post, and the Financial Times.